OR WAIT 15 SECS
BIA Separations has announced the company has signed agreements with Bioscience companies, GeneX India Biosciences, Chennai, India and IT Technologies (IT Tech), Singapore. Both Companies will act as sole distributors of BIA Separations’ products and services across their respective regions of India, and Singapore and Malaysia.
Download Issue : The Column-08-06-2020
“We are delighted to have GeneX India and IT Tech on board and look forward to jointly providing researchers and process developers across Asia with our state-of-the-art bioprocessing technologies and services,” said Ingo S. Nagler, Business Development Officer,
BIA Separations provides research and method development services for the purification of large and complex biomolecules including those with therapeutic applications. Through the agreements, both distributors will provide academic researchers, CMOs, and biopharmaceutical companies access to BIA Separations’ proprietary analytical and preparative purification technologies for cell and gene therapies, including viral vectors, nucleic acids, phages, and exosomes.
“We are very proud to be working with the team [BIA Separations] to ensure its leading purification technologies and expertise are available to research and bioproduction customers throughout India,” said Felix Paul, Managing Director GeneX India Biosciences.
“Cell and gene therapy is still at an early stage here [Malaysia], and therefore this is an exciting time to be signing a partnership with BIA Separations, enabling us to offer the Company’s products and services across research in this high-potential field,” said Danapalan Arumugam, Managing Director at IT Tech.
For more information, please visit: www.biaseparations.com